RAD51D

There are 7 papers on RAD51D in aging research: 1 trial and 2 observational studies in people, 3 reviews.

7 papers study it1 finding

HGNC NCBI Gene Taxon

1 new paper in 30 daysSee all 7 papers on RAD51D

Human trial1
Humans2

Associations

1

Ovarian cancer

upin humans1

1 study

RAD51D is associated with ovarian cancer in humans (heterozygous germline pathogenic variants).
“RAD51C, RAD51D, and BRIP1 are moderate (intermediate) penetrance ovarian cancer predisposition genes.”
Reviewheterozygous germline pathogenic variants
Management of individuals with heterozygous germline pathogenic variants in RAD51C, RAD51D, and BRIP1: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)
Genetics in medicine : official journal of the American College of Medical GeneticsOct 7, 2025

More on Ovarian cancer

Latest

3 papers in 12 months

Obstetrical & Gynecological SurveyNov 5

Comment on “Patient-Centered Approach to Surgical Prevention of Ovarian Cancer: A Nonrandomized Clinical Trial”

Trial in 334 peopleOvarian cancer

European Journal of Breast HealthJun 19

Hereditary Cancer Genetic Testing for All? A Retrospective Analysis on Genetic Mutations Found in Individuals Not Meeting NCCN® Guidelines

Cross-sectional study of 8,100 peopleInterventions

International Journal of Gynecological CancerMay 16

FIMBRIMENOP-2402 trial: evaluating fimbriectomy with delayed oophorectomy in patients with high-risk tubo-ovarian cancer

Study protocolReproductive system

American Journal of Obstetrics and GynecologyNov 4

Salpingectomy in individuals at high risk for tubo-ovarian cancer: consensus and precaution

CommentaryReproductive system

Genetics in MedicineOct 10

Management of individuals with heterozygous germline pathogenic variants in RAD51C, RAD51D, and BRIP1: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)

ReviewIndustry & policy

BJOGOct 22

Risk-Reducing Salpingo-Oophorectomy and the Use of Hormone Replacement Therapy Below the Age of Natural Menopause: Scientific Impact Paper No. 66 October 2021: Scientific Impact Paper No. 66

ReviewHormone replacement therapy

Journal of Geriatric OncologyOct 3

Older breast cancer survivors may harbor hereditary cancer predisposition pathogenic variants and are at risk for clonal hematopoiesis

Case-control study of 44 peopleBreast cancer